NLRP3 and metabolic dysfunction-associated steatotic liver disease: Moreover, patients with severe nonalcoholic fatty liver disease showed increased levels of NLRP3 and IL-1β mRNA that correlated with the expression of COL1A1, a marker of liver fibrosis (Wree et al., 2014).